Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (401-410 of 496) with videos related to

Pageof 50
Sort By:
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
RMD Open|July 23, 2024
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohortAnna Molto, Chris Serrand, Sandrine Alonso, et al.
Fundamental & Clinical Pharmacology|October 18, 2021
Tofacitinib improved peripheral endothelial dysfunction and brain-derived neurotrophic factor levels in the rat adjuvant-induced arthritis modelPerle Totoson, Célian Peyronnel, Aurore Quirié, et al.
The Journal of Rheumatology|March 17, 2006
Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significanceEric Toussirot, Edouard Pertuiset, Antoine Martin, et al.
Joint Bone Spine|February 7, 2018
2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritisDaniel Wendling, Cédric Lukas, Clément Prati, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Arthritis Research & Therapy|July 20, 2010
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control studyMélanie Gilson, Laure Gossec, Xavier Mariette, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case seriesHervé Lobbes, Charles Dervout, Eric Toussirot, et al.
The Journal of Dermatological Treatment|September 15, 2015
Observational case series on adalimumab-induced paradoxical hidradenitis suppurativaMarine Delobeau, Ahlam Abdou, Eve Puzenat, et al.
Rheumatology (Oxford, England)|September 24, 2014
Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practiceClémentine Fortunet, Yves-Marie Pers, Joseph Lambert, et al.
Pageof 50

Showing results (401-410 of 496) with videos related to

Sort By:
Pageof 50
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
RMD Open|July 23, 2024
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohortAnna Molto, Chris Serrand, Sandrine Alonso, et al.
Fundamental & Clinical Pharmacology|October 18, 2021
Tofacitinib improved peripheral endothelial dysfunction and brain-derived neurotrophic factor levels in the rat adjuvant-induced arthritis modelPerle Totoson, Célian Peyronnel, Aurore Quirié, et al.
The Journal of Rheumatology|March 17, 2006
Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significanceEric Toussirot, Edouard Pertuiset, Antoine Martin, et al.
Joint Bone Spine|February 7, 2018
2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritisDaniel Wendling, Cédric Lukas, Clément Prati, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Arthritis Research & Therapy|July 20, 2010
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control studyMélanie Gilson, Laure Gossec, Xavier Mariette, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case seriesHervé Lobbes, Charles Dervout, Eric Toussirot, et al.
The Journal of Dermatological Treatment|September 15, 2015
Observational case series on adalimumab-induced paradoxical hidradenitis suppurativaMarine Delobeau, Ahlam Abdou, Eve Puzenat, et al.
Rheumatology (Oxford, England)|September 24, 2014
Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practiceClémentine Fortunet, Yves-Marie Pers, Joseph Lambert, et al.
Pageof 50